Development and In Vitro Evaluation of Oral Capsules from <i>Antiaris</i>: A Convenient Substitute for Peripheral Neuropathy

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Formulation code</td><td class="align_center">Average disintegration time (min)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">A01</td><td class="align_center">6.50 ± 0.495</td></tr><tr><td class="align_left">A02</td><td class="align_center">3.58 ± 0.028</td></tr><tr><td class="align_left">A03</td><td class="align_center">6.60 ± 0.099</td></tr><tr><td class="align_left">A04</td><td class="align_center">3.25 ± 0.057</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Disintegration time of <i>Antiaris africana</i> capsules (<i>n</i> = 6).</div>

Advances in Pharmacological and Pharmaceutical Sciences

tab4

Table 4

Table 4: Development and In Vitro Evaluation of Oral Capsules from <i>Antiaris</i>: A Convenient Substitute for Peripheral Neuropathy 

Advances in Pharmacological and Pharmaceutical Sciences

Development and In Vitro Evaluation of Oral Capsules from Antiaris: A Convenient Substitute for Peripheral Neuropathy

Table 4